Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Complementary approaches to assessing risk factors for interval breast cancer.

Lowery JT, Byers T, Hokanson JE, Kittelson J, Lewin J, Risendal B, Singh M, Mouchawar J.

Cancer Causes Control. 2011 Jan;22(1):23-31. doi: 10.1007/s10552-010-9663-x. Epub 2010 Oct 27.

PMID:
20978835
2.

Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up.

Corsetti V, Houssami N, Ghirardi M, Ferrari A, Speziani M, Bellarosa S, Remida G, Gasparotti C, Galligioni E, Ciatto S.

Eur J Cancer. 2011 May;47(7):1021-6. doi: 10.1016/j.ejca.2010.12.002. Epub 2011 Jan 4.

PMID:
21211962
3.

Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.

Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, White E.

J Natl Cancer Inst. 2000 Jul 5;92(13):1081-7.

PMID:
10880551
4.

Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force [Internet].

Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan.

5.

Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening.

Houssami N, Abraham LA, Kerlikowske K, Buist DS, Irwig L, Lee J, Miglioretti DL.

Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):946-61. doi: 10.1158/1055-9965.EPI-12-1208-T. Epub 2013 Mar 19.

6.

The natural history of invasive breast cancers detected by screening mammography.

Zahl PH, Maehlen J, Welch HG.

Arch Intern Med. 2008 Nov 24;168(21):2311-6. doi: 10.1001/archinte.168.21.2311.

7.

Biennial versus annual mammography and the risk of late-stage breast cancer.

White E, Miglioretti DL, Yankaskas BC, Geller BM, Rosenberg RD, Kerlikowske K, Saba L, Vacek PM, Carney PA, Buist DS, Oestreicher N, Barlow W, Ballard-Barbash R, Taplin SH.

J Natl Cancer Inst. 2004 Dec 15;96(24):1832-9.

PMID:
15601639
8.

Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial.

Nixon RM, Pharoah P, Tabar L, Krusemo UB, Duffy SW, Prevost TC, Chen HH.

Rev Epidemiol Sante Publique. 2000 Aug;48(4):325-31.

PMID:
11011299
9.
10.

Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands.

van Gils CH, Otten JD, Verbeek AL, Hendriks JH, Holland R.

J Epidemiol Community Health. 1998 Apr;52(4):267-71.

11.

Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.

Ng EH, Ng FC, Tan PH, Low SC, Chiang G, Tan KP, Seow A, Emmanuel S, Tan CH, Ho GH, Ng LT, Wilde CC.

Cancer. 1998 Apr 15;82(8):1521-8. Erratum in: Cancer 1998 Jul 1;83(1):191.

PMID:
9554530
12.

Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.

Taylor R, Page A, Bampton D, Estoesta J, Rickard M.

J Med Screen. 2004;11(4):199-206.

PMID:
15563775
13.

MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts: The DENSE Trial Study Design.

Emaus MJ, Bakker MF, Peeters PH, Loo CE, Mann RM, de Jong MD, Bisschops RH, Veltman J, Duvivier KM, Lobbes MB, Pijnappel RM, Karssemeijer N, de Koning HJ, van den Bosch MA, Monninkhof EM, Mali WP, Veldhuis WB, van Gils CH.

Radiology. 2015 Nov;277(2):527-37. doi: 10.1148/radiol.2015141827. Epub 2015 Jun 23.

PMID:
26110667
14.

Annual or biennial mammography screening for women at a higher risk with a family history of breast cancer: prognostic indicators of screen-detected cancers in New South Wales, Australia.

Randall D, Morrell S, Taylor R, Hung WT.

Cancer Causes Control. 2009 Jul;20(5):559-66. doi: 10.1007/s10552-008-9264-0. Epub 2008 Nov 18.

PMID:
19015941
15.

Prospective breast cancer risk prediction model for women undergoing screening mammography.

Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, Tice JA, Buist DS, Geller BM, Rosenberg R, Yankaskas BC, Kerlikowske K.

J Natl Cancer Inst. 2006 Sep 6;98(17):1204-14.

PMID:
16954473
16.

Positive predictive value of screening mammography by age and family history of breast cancer.

Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V.

JAMA. 1993 Nov 24;270(20):2444-50.

PMID:
8230621
18.

Interval cancers in the Norwegian breast cancer screening program: frequency, characteristics and use of HRT.

Wang H, Bjurstam N, Bjørndal H, Braaten A, Eriksen L, Skaane P, Vitak B, Hofvind S, Thoresen SØ.

Int J Cancer. 2001 Nov;94(4):594-8.

19.

Impact of false-positive mammography on subsequent screening attendance and risk of cancer.

McCann J, Stockton D, Godward S.

Breast Cancer Res. 2002;4(5):R11. Epub 2002 Jul 17.

20.

Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.

Chiarelli AM, Kirsh VA, Klar NS, Shumak R, Jong R, Fishell E, Yaffe MJ, Boyd NF.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1856-62.

Supplemental Content

Support Center